Press Releases
Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Australian Healthcare Herald.
60 Degrees Pharmaceuticals Selects Icahn School of Medicine at Mount Sinai as Central Clinical Trial Site for Phase II Study to Evaluate Tafenoquine for Chronic Babesiosis
GlobeNewswire, Inc.
·
August 19, 2025
90-day trial measuring change in general fatigue in chronic babesiosis patients Enrollment expected to commence Q4 2025 and to be completed by Q2 2026 Site has clinical expertise in infectious disease trials and access to a robust patient...
Groundbreaking Gut, Metabolic and Neurological Support Protocol for Children with Special Needs
EIN Presswire
·
August 19, 2025
This protocol, the result of years of research into the gut and metabolic factors affecting children’s health, offers new hope for children with special needs. CLEARWATER, FL, UNITED STATES, August 19, 2025 /EINPresswire.com/ -- Purelife Health...
Profusa Welcomes Former Acting U.S. Veterans Affairs Secretary Peter O’Rourke as Lead Independent Director; Adds Seasoned Finance Executive Fred Knechtel as CFO
GlobeNewswire, Inc.
·
August 19, 2025
Board addition served in the Trump Administration, overseeing 1,300 facilities serving more than 9 million veterans; New CFO has led finance and operations at companies including Northrop Grumman, Stanley Black & Decker, and DuPont Berkeley,...
Teleflex Announces the Launch of Barrigel™ Rectal Spacer in Japan as a Proven Safe and Effective Option to Minimize the Harmful Long-Term Side Effects of Prostate Radiation Therapy
GlobeNewswire, Inc.
·
August 19, 2025
Innovative hyaluronic acid technology delivers enhanced control and precision, significantly lowering the risk of rectal toxicity during prostate radiation treatment.1-4 Initial cases have now been performed in Japan. WAYNE, Pa., Aug. 19, 2025...
Pain Clinics Promote Road Safety According To New Research; Olumuyiwa Bamgbade, Salem Pain Clinic, Canada
EIN Presswire
·
August 24, 2025
New Research Shows That Pain Clinics Enhance Driving Towards Road Safety; Olumuyiwa Bamgbade, Salem Pain Clinic, BC, Canada SURREY, BC, CANADA, August 24, 2025 /EINPresswire.com/ -- In the public imagination, pain clinics are usually associated...
Allarity Therapeutics Provides Second Quarter 2025 Update, Highlighting Clinical Progress, IP Expansion, and New Partnerships
GlobeNewswire, Inc.
·
August 15, 2025
- Successfully initiated enrollment in advanced Phase 2 ovarian cancer trial - Expanded global IP protection by securing Australian patent acceptance for the stenoparib DRP® companion diagnostic - Secured new service contract with EU biotech for...
Propanc Biopharma Announces Nasdaq Uplisting and Pricing of $4 Million Public Offering
GlobeNewswire, Inc.
·
August 15, 2025
MELBOURNE, Australia, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Propanc Biopharma, Inc. (OTC Pink: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel cancer treatments for patients suffering from recurring and metastatic...
BellaSeno Establishes High-Profile Clinical Advisory Board
GlobeNewswire, Inc.
·
August 18, 2025
Leading international experts to support clinical development of BellaSeno´s pioneering resorbable breast implants Pivotal clinical trial to be initiated shortly Leipzig, Germany / Brisbane, Australia, August 18, 2025 – BellaSeno GmbH, an ISO...
Glucotrack Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights
GlobeNewswire, Inc.
·
August 14, 2025
On track to implant first patients in long-term, multicenter feasibility study of the fully implantable continuous blood glucose monitor (CBGM) system in Australia in Q3 2025 Investigational Device Exemption submission to FDA of novel CBGM...
Tilray Brands Reconfirms Strategy to Regain Nasdaq Compliance; Requests Extension to Meet Listing Requirements
GlobeNewswire, Inc.
·
August 14, 2025
NEW YORK and LEAMINGTON, Ontario, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a global lifestyle consumer packaged goods company at the forefront of the cannabis, beverage, and...
TOTAL PRINT MANAGEMENT ASSIST IAN LAZAR LIFESTYLE MAGAZINE WITH MONTHLY FEATURES ON AN ARRAY OF OFFICE PRINTING MATTERS
EIN Presswire
·
August 17, 2025
Ian Lazar Digital confirmed to Eleven Media they will commence in September feature posts that focus on insights related to hi-tech office printing matters. SYDNEY , NSW, AUSTRALIA, August 18, 2025 /EINPresswire.com/ -- Ian Lazar Digital's...
IAN LAZAR LIFESTYLE MAGAZINE COMMENCE MONTHLY FEATURES ON AN ARRAY OF LEGAL MATTERS
EIN Presswire
·
August 17, 2025
Ian Lazar Digital confirmed to Eleven Media they will commence in September feature posts that focus on insights related to an array of requested legal matters. SYDNEY , NSW, AUSTRALIA, August 18, 2025 /EINPresswire.com/ -- Ian Lazar Digital's...
Tilray Medical Forms Strategic Partnership in Italy to Broaden Access to Medical Cannabis Extracts
GlobeNewswire, Inc.
·
August 13, 2025
NEW YORK, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Tilray Medical, a division of Tilray Brands, Inc. ("Tilray") (Nasdaq: TLRY; TSX: TLRY) and a global leader in medical cannabis, empowering the therapeutic alliance between patients and healthcare...
Hyperfine, Inc. Reports Second Quarter 2025 Financial Results
GlobeNewswire, Inc.
·
August 13, 2025
GUILFORD, Conn., Aug. 13, 2025 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable magnetic resonance (MR) brain imaging...
AI in Remote Patient Monitoring (RPM) Market to Reach USD 8,438.5 Million by 2030 | MarketsandMarkets™
GlobeNewswire, Inc.
·
August 20, 2025
Delray Beach, FL, Aug. 20, 2025 (GLOBE NEWSWIRE) -- The global AI in remote patient monitoring market, valued at US$1551.8 million in 2023, stood at US$1,967.7 million in 2024 and is projected to advance at a resilient CAGR of 27.5% from 2024 to...
Cell Dissociation Market Size Projected to Attain USD 1,451.89 Million by 2034
GlobeNewswire, Inc.
·
August 20, 2025
Ottawa, Aug. 20, 2025 (GLOBE NEWSWIRE) -- The global cell dissociation market size valued at USD 406.36 million in 2024, is projected to reach approximately USD 1,451.89 million by 2034, growing at a CAGR of 13.58%, according to a study by Towards...
Global Hearing Aids Market to Surpass USD 14.42 Billion by 2030 | MarketsandMarkets™
GlobeNewswire, Inc.
·
August 20, 2025
Delray Beach, FL, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Growing Prevalence of Hearing Loss and Smart Technology Adoption Fuel Sector Expansion The global hearing aids market, valued at US$9.74 billion in 2024, stood at US$10.35 billion in 2025 and is...
Genome Editing Market to Grow at 16.9% CAGR Through 2030
GlobeNewswire, Inc.
·
August 20, 2025
Boston, Aug. 20, 2025 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research, the “Genome Editing: Technologies and Global Markets” is projected to grow from $10.8 billion in 2025 to $23.7 billion by the end of 2030, at a compound...
Anteris Announces Results for the Second Quarter of 2025
GlobeNewswire, Inc.
·
August 11, 2025
MINNEAPOLIS and BRISBANE, Australia, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. (Anteris or the Company) (NASDAQ: AVR, ASX: AVR) a global structural heart company committed to designing, developing, and commercialising...
Cocrystal Pharma Reports Second Quarter 2025 Financial Results and Provides Updates on its Antiviral Drug-Development Programs
GlobeNewswire, Inc.
·
August 14, 2025
Favorable CDI-988 Phase 1 safety and tolerability reported Challenge study with CDI-988 as a norovirus preventive and treatment planned later this year BOTHELL, Wash., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP)...